URGN earnings

UroGen Pharma (URGN) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.

URGN earnings history

QuarterReportedEPSEstimateSurpriseRevenue
Q3 2026Nov 4, 2026-0.030.11-128.38%$89.00M
Q2 2026Aug 5, 2026-0.28-0.27-5.66%$72.46M
Q1 2026May 6, 2026-0.47-0.5616.07%$50.96M
Q4 2025Mar 2, 2026-0.54-0.52-4.25%$37.84M
Q3 2025Nov 6, 2025-0.69-0.724.17%$27.48M
Q2 2025Aug 7, 2025-1.05-0.82-28.05%$24.21M
Q1 2025May 12, 2025-0.92-0.83-10.84%$20.25M
Q4 2024Mar 10, 2025-0.80-0.69-15.94%$24.57M
Q3 2024Nov 6, 2024-0.55-0.8434.52%$25.20M
Q2 2024Aug 13, 2024-0.91-0.82-10.98%$21.85M
Q1 2024May 13, 2024-0.97-0.93-4.30%$18.78M
Q4 2023Mar 14, 2024-0.72-0.67-7.46%$23.53M
Q3 2023Nov 14, 2023-0.68-0.8923.60%$20.85M
Q2 2023Aug 10, 2023-1.03-1.138.85%$21.14M
Q1 2023May 11, 2023-1.30-1.396.47%$17.19M
Q4 2022Mar 16, 2023-1.22-1.12-8.93%$18.09M
Q3 2022Nov 10, 2022-1.13-1.227.38%$16.10M